Guidelines and strategy of the International Conference of Harmonization (ICH) and its member states to overcome existing impurity control problems for antibiotics in China / 中国天然药物
Chinese Journal of Natural Medicines (English Ed.)
;
(6): 498-506, 2015.
Artículo
en Inglés
| WPRIM
| ID: wpr-812517
ABSTRACT
In the present report, we review the technical guidelines and principles on impurity research and control for antibiotics established by various agencies, including the International Conference of Harmonization (ICH), the US Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the China Food and Drug Administration (CFDA). Progresses with the US Pharmacopoeia (USP), the European Pharmacopoeia (EP) and the Chinese Pharmacopoeia (ChP) to control impurities in antibiotics are also presented. Next, our discussion is focused on analyzing the CFDA's requirements on impurity research and control for antibiotics, and the implementation of ICH, FDA and other technical guidelines for generic drugs impurity control in China. Existing problems are further reviewed, in order to improve the overall process for the control of antibiotic purity.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Farmacopeas como Asunto
/
Control de Calidad
/
Estándares de Referencia
/
Investigación
/
Estados Unidos
/
United States Food and Drug Administration
/
Preparaciones Farmacéuticas
/
China
/
Contaminación de Medicamentos
/
Medicamentos Genéricos
Tipo de estudio:
Guía de Práctica Clínica
/
Investigación cualitativa
Límite:
Humanos
País/Región como asunto:
America del Norte
/
Asia
/
Europa
Idioma:
Inglés
Revista:
Chinese Journal of Natural Medicines (English Ed.)
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS